Samir Rashmikant Patel - Jun 30, 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Wendy F. DiCicco, as Attorney-in-Fact for Samir Patel
Stock symbol
AKTX
Transactions as of
Jun 30, 2024
Transactions value $
$0
Form type
4
Date filed
7/2/2024, 04:30 PM
Previous filing
Jun 4, 2024
Next filing
Oct 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $0 +91.4M $0.00 91.4M Jun 30, 2024 Direct F1, F2
holding AKTX Ordinary Shares, par value $0.0001 per share 3.41B Jun 30, 2024 PranaBio Investments LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2 These shares represent restricted stock units ("RSUs") granted under the Issuer's 2023 Equity Incentive Plan, with each such RSU representing the right to receive one ordinary share, par value $0.0001. One-hundered percent (100%) of the RSUs vested on the date of grant, or June 30, 2024.

Remarks:

See Exhibit 24.1 - Power of Attorney